SUPPLEMENTARY MATERIAL: Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study

Published: 29 July 2025| Version 1 | DOI: 10.17632/krgr4mrh56.1
Contributors:
Todd Schlesinger, M. Shane Chapman, John H. Tu, Joel L. Cohen, John Strasswimmer, Nathalie C. Zeitouni, Abel Torres, S. Sasha Jazayeri, Mitchel P. Goldman, Sherrif F. Ibrahim, Edward L. Lain, Megan P. Couvillion, Suzanne Bruce, Vivian T. Laquer, C. William Hanke, David Ozog, Jane Schneider, Orit Markowitz, Brian Berman, Mark S. Nestor, Michael H. Gold, Girish S. Munavalli, Douglass W. Forsha, Daniel M. Siegel, David Mrohs, Beate Schmitz, Ruth Schäning, Nicole Pospiech, Jon Lyons, Montserrat Foguet, Matthias Lübbert, Hermann Lübbert, David M. Pariser

Description

Supplementary material for the manuscript "Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study"

Files

Categories

Basal Cell Carcinoma, Photodynamic Therapy, Aminolevulinic Acid, Randomized Clinical Trial

Funders

  • Biofrontera Bioscience GmbH

Licence